Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Genetic Disorders (2023)
5.2 Testing Volume and Growth Trends (2020-2032)
5.3 Healthcare Expenditure on Hereditary Testing (2023)
5.4 Technological Advancements in Testing Methods
5.5 Regulatory and Compliance Landscape
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Hereditary Testing Market Segmentation, By Disease Type
7.1 Chapter Overview
7.2 Hereditary Cancer Testing
7.2.1 Hereditary Cancer Testing Market Trends Analysis (2020-2032)
7.2.2 Hereditary Cancer Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Lung Cancer
7.2.3.1 Lung Cancer Market Trends Analysis (2020-2032)
7.2.3.2 Lung Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Breast Cancer
7.2.4.1 Breast Cancer Market Trends Analysis (2020-2032)
7.2.4.2 Breast Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Cervical Cancer
7.2.5.1 Cervical Cancer Market Trends Analysis (2020-2032)
7.2.5.2 Cervical Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Colorectal Cancer
7.2.6.1 Colorectal Cancer Market Trends Analysis (2020-2032)
7.2.6.2 Colorectal Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Prostate Cancer
7.2.7.1 Prostate Cancer Market Trends Analysis (2020-2032)
7.2.7.2 Prostate Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.8 Ovarian Cancer
7.2.8.1 Ovarian Cancer Market Trends Analysis (2020-2032)
7.2.8.2 Ovarian Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.9 Stomach/Gastric Cancer
7.2.9.1 Stomach/Gastric Cancer Market Trends Analysis (2020-2032)
7.2.9.2 Stomach/Gastric Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.10 Uterine Cancer
7.2.10.1 Uterine Cancer Market Trends Analysis (2020-2032)
7.2.10.2 Uterine Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.11 Melanoma
7.2.11.1 Melanoma Market Trends Analysis (2020-2032)
7.2.11.2 Melanoma Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.12 Sarcoma
7.2.12.1 Sarcoma Market Trends Analysis (2020-2032)
7.2.12.2 Sarcoma Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.13 Pancreatic Cancer
7.2.13.1 Pancreatic Cancer Market Trends Analysis (2020-2032)
7.2.13.2 Pancreatic Cancer Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.14 Others
7.2.14.1 Others Market Trends Analysis (2020-2032)
7.2.14.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Hereditary Non-cancer Testing
7.3.1 Hereditary Non-cancer Testing Market Trends Analysis (2020-2032)
7.3.2 Hereditary Non-cancer Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Genetic Tests
7.3.3.1 Genetic Tests Market Trends Analysis (2020-2032)
7.3.3.2 Genetic Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.3 Cardiac Diseases
7.3.3.3.1 Cardiac Diseases Market Trends Analysis (2020-2032)
7.3.3.3.2 Cardiac Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.4 Rare Diseases
7.3.3.4.1 Rare Diseases Market Trends Analysis (2020-2032)
7.3.3.4.2 Rare Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.5 Other Diseases
7.3.3.5.1 Other Diseases Market Trends Analysis (2020-2032)
7.3.3.5.2 Other Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Preimplantation Genetic Diagnosis & Screening
7.3.4.1 Preimplantation Genetic Diagnosis & Screening Market Trends Analysis (2020-2032)
7.3.4.2 Preimplantation Genetic Diagnosis & Screening Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 Newborn Genetic Screening
7.3.5.1 Newborn Genetic Screening Market Trends Analysis (2020-2032)
7.3.5.2 Newborn Genetic Screening Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.6 Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests
7.3.6.1 Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests Market Trends Analysis (2020-2032)
7.3.6.2 Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Hereditary Testing Market Segmentation, By Technology
8.1 Chapter Overview
8.2 Cytogenetic
8.2.1 Cytogenetic Market Trends Analysis (2020-2032)
8.2.2 Cytogenetic Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Biochemical
8.3.1 Biochemical Market Trends Analysis (2020-2032)
8.3.2 Biochemical Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Molecular Testing
8.4.1 Molecular Testing Market Trends Analysis (2020-2032)
8.4.2 Molecular Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.2.4 North America Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.2.5.2 USA Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.2.6.2 Canada Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.2.7.2 Mexico Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.1.5.2 Poland Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.1.6.2 Romania Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.4 Western Europe Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.5.2 Germany Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.6.2 France Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.7.2 UK Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.8.2 Italy Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.9.2 Spain Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.12.2 Austria Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.4 Asia Pacific Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.5.2 China Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.5.2 India Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.5.2 Japan Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.6.2 South Korea Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.2.7.2 Vietnam Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.8.2 Singapore Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.9.2 Australia Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.1.4 Middle East Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.1.5.2 UAE Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.2.4 Africa Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Hereditary Testing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.6.4 Latin America Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.6.5.2 Brazil Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.6.6.2 Argentina Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.6.7.2 Colombia Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Hereditary Testing Market Estimates and Forecasts, By Disease Type (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Hereditary Testing Market Estimates and Forecasts, By Technology (2020-2032) (USD Billion)
10. Company Profiles
10.1 Invitae Corporation
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Myriad Genetics, Inc.
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Quest Diagnostics Incorporated
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Laboratory Corporation of America Holdings (LabCorp)
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Illumina, Inc.
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Thermo Fisher Scientific, Inc.
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 23andMe, Inc.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Fulgent Genetics
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Color Health, Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Bionano Genomics, Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
